Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: A randomized comparison of treatment compliance
Objectives: To compare weekly and three-weekly cisplatin as an adjunct to radiation therapy in high-risk early-stage cervical cancer after surgery with regard to treatment compliance. Material and Method: From June 1st, 2003 to February 29th, 2004, the authors performed a randomized trial of radioth...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33645215997&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/62326 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-62326 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-623262018-09-11T09:25:41Z Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: A randomized comparison of treatment compliance Bandit Chumworathayi Prapaporn Suprasert Kittipat Charoenkwan Jatupol Srisomboon Chailert Phongnarisorn Sitticha Siriaree Chalong Cheewakriangkrai Jaruwan Tantipalakorn Chamnan Kiatpeerakul Aree Pantusart Medicine Objectives: To compare weekly and three-weekly cisplatin as an adjunct to radiation therapy in high-risk early-stage cervical cancer after surgery with regard to treatment compliance. Material and Method: From June 1st, 2003 to February 29th, 2004, the authors performed a randomized trial of radiotherapy in combination with two concurrent chemotherapy regimens - weekly or three-weekly cisplatin - in patients with high-risk cervical cancer FIGO stage I-IIA after surgery. Women with primary invasive squamous-cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the cervix were enrolled. The patients also had to have an absolute neutrophil count of at least 1,500 cells per cubic millimeter, a platelet count of at least 75,000 cells per cubic millimeter, a creatinine clearance higher than 40 milliliter per minute, and adequate hepatic function. All patients received external-beam radiotherapy according to a strict protocol. Patients were randomly assigned to receive one of two chemotherapy regimens: 75 mg per square meter of cisplatin on days 1, 22, 43 and 64 or every three weeks for 4 cycles (group 1) or 40 mg per square meter of cisplatin per week for six cycles (group 2). Results: The analysis included 40 women. The first group that received three-weekly cisplatin had a higher rate of incomplete and delayed treatments than the second group that received weekly cisplatin (p < 0.001 and p = 0.0236 respectively). The relative risks of delayed courses were 2.06 (95 percent confidence interval, 1.15 to 3.68) for group 1, compared with group 2. The toxicity-related incomplete treatments rate and G-CSF doses used were significantly higher in group 1 than in group 2. Conclusion: Concurrent chemoradiation with weekly cisplatin regimen has more complete treatment rate and less delayed courses than that with three- weekly cisplatin among women with high-risk cervical cancer after surgery. 2018-09-11T09:25:41Z 2018-09-11T09:25:41Z 2005-11-01 Journal 01252208 01252208 2-s2.0-33645215997 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33645215997&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/62326 |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
topic |
Medicine |
spellingShingle |
Medicine Bandit Chumworathayi Prapaporn Suprasert Kittipat Charoenkwan Jatupol Srisomboon Chailert Phongnarisorn Sitticha Siriaree Chalong Cheewakriangkrai Jaruwan Tantipalakorn Chamnan Kiatpeerakul Aree Pantusart Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: A randomized comparison of treatment compliance |
description |
Objectives: To compare weekly and three-weekly cisplatin as an adjunct to radiation therapy in high-risk early-stage cervical cancer after surgery with regard to treatment compliance. Material and Method: From June 1st, 2003 to February 29th, 2004, the authors performed a randomized trial of radiotherapy in combination with two concurrent chemotherapy regimens - weekly or three-weekly cisplatin - in patients with high-risk cervical cancer FIGO stage I-IIA after surgery. Women with primary invasive squamous-cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the cervix were enrolled. The patients also had to have an absolute neutrophil count of at least 1,500 cells per cubic millimeter, a platelet count of at least 75,000 cells per cubic millimeter, a creatinine clearance higher than 40 milliliter per minute, and adequate hepatic function. All patients received external-beam radiotherapy according to a strict protocol. Patients were randomly assigned to receive one of two chemotherapy regimens: 75 mg per square meter of cisplatin on days 1, 22, 43 and 64 or every three weeks for 4 cycles (group 1) or 40 mg per square meter of cisplatin per week for six cycles (group 2). Results: The analysis included 40 women. The first group that received three-weekly cisplatin had a higher rate of incomplete and delayed treatments than the second group that received weekly cisplatin (p < 0.001 and p = 0.0236 respectively). The relative risks of delayed courses were 2.06 (95 percent confidence interval, 1.15 to 3.68) for group 1, compared with group 2. The toxicity-related incomplete treatments rate and G-CSF doses used were significantly higher in group 1 than in group 2. Conclusion: Concurrent chemoradiation with weekly cisplatin regimen has more complete treatment rate and less delayed courses than that with three- weekly cisplatin among women with high-risk cervical cancer after surgery. |
format |
Journal |
author |
Bandit Chumworathayi Prapaporn Suprasert Kittipat Charoenkwan Jatupol Srisomboon Chailert Phongnarisorn Sitticha Siriaree Chalong Cheewakriangkrai Jaruwan Tantipalakorn Chamnan Kiatpeerakul Aree Pantusart |
author_facet |
Bandit Chumworathayi Prapaporn Suprasert Kittipat Charoenkwan Jatupol Srisomboon Chailert Phongnarisorn Sitticha Siriaree Chalong Cheewakriangkrai Jaruwan Tantipalakorn Chamnan Kiatpeerakul Aree Pantusart |
author_sort |
Bandit Chumworathayi |
title |
Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: A randomized comparison of treatment compliance |
title_short |
Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: A randomized comparison of treatment compliance |
title_full |
Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: A randomized comparison of treatment compliance |
title_fullStr |
Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: A randomized comparison of treatment compliance |
title_full_unstemmed |
Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: A randomized comparison of treatment compliance |
title_sort |
weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage i-iia cervical cancer after surgery: a randomized comparison of treatment compliance |
publishDate |
2018 |
url |
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33645215997&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/62326 |
_version_ |
1681425786024755200 |